Vascular Biogenics (NASDAQ:VBLT) Coverage Initiated at StockNews.com

Stock analysts at StockNews.com assumed coverage on shares of Vascular Biogenics (NASDAQ:VBLT – Get Rating) in a note issued to investors on Friday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Vascular Biogenics Stock Performance NASDAQ:VBLT opened at $0.14 on Friday. The stock’s fifty day moving average price is $0.13 and its […]